Internal Server Error

Genechem - About the company

Genechem is a series C company based in Shanghai (China), founded in 2002 by Honghua Qu. It operates as a Products and services in molecular biology. Genechem has raised $56.4M in funding from Humanwell Healthcare and Free Trade Zone Fund. The company has 687 active competitors, including 76 funded and 75 that have exited. Its top competitors include companies like Strand Life Sciences, Illumina and Arbor Biotechnologies.

Company Details

Genechem engages in developing products and services for molecular biology. The product portfolio of the company includes Gene import tool, Lentivirus Lenti-KD, Lenti-OE, Lenti-CRISPR, Adenovirus Adv-KD, Adv-OE, Adeno - associated virus AAV-KD, AAV-OE, plasmid Trans-KD, Trans-OE library, CDNA-SET, shRNA-SET, Non-coding-SET, CRISPR-Pool, Gene regulation method Gene down regulation Lenti-KD, Lenti-CRISPR, Adv-KD, AAV-KD, Trans-KD, ShRNA-SET, Non-coding-SET, Gene uptake Lenti-OE, Lenti-CRISPR, Adv-OE, AAV-OE, Trans-OE CDNA-SET, Non-coding-SET and, CRISPR-Pool. Additionally, it offers genomics services and custom animal model development services.
Email ID
*****@genechem.com.cn
Phone Number
+86 **********
Key Metrics
Founded Year
2002
Location
Shanghai, China
Stage
Series C
Total Funding
$56.4M in 2 rounds
Latest Funding Round
Ranked
Employee Count
6 as on Jul 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Genechem's company profile

Genechem's funding and investors

Genechem has raised a total funding of $56.4M over 2 rounds. Its first funding round was on Mar 13, 2019. Its latest funding round was a Series C round on Apr 02, 2020 for $*****. 3 investors participated in its latest round. Genechem has 4 institutional investors.

Here is the list of recent funding rounds of Genechem:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Apr 02, 2020
2709695
Series C
2903057
5278417
5870065
3419449
Mar 13, 2019
1962151
Series A
1692437
5687324
7785342
lockAccess funding benchmarks and valuations. Sign up today!

Genechem's founders and board of directors

Founder? Claim Profile
The founders of Genechem is Honghua Qu.
Here are the details of Genechem's key team members:

Genechem's employee count trend

Genechem has 6 employees as of Jul 26. Here is Genechem's employee count trend over the years:
Employee count trend for Genechem
lockUncover Genechem's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Genechem's Competitors and alternates

Top competitors of Genechem include Strand Life Sciences, Illumina and Arbor Biotechnologies. Here is the list of Top 10 competitors of Genechem, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Strand Life Sciences
Strand Life Sciences
2000, Bengaluru (India), Acquired
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
$34.9M
74/100
2nd
Logo for Illumina
Illumina
1993, San Diego (United States), Public
Developer of technologies for analysis of genetic variation and function
$28M
71/100
3rd
Logo for Arbor Biotechnologies
Arbor Biotechnologies
2016, Cambridge (United States), Series C
Provider of genomic technologies and drug discovery platform
$304M
64/100
4th
Logo for BGI
BGI
1999, Shenzhen (China), Public
Provider of services in genome sequencing
-
64/100
5th
Logo for MGI
MGI
2016, Shenzhen (China), Series B
Provider of gene sequencing instruments, reagents, equipment, and related products
$1B
63/100
6th
Logo for Eclipse Bio
Eclipse Bio
2017, San Diego (United States), Series A
Developer of cell-free immunoassay
$18.9M
61/100
7th
Logo for Factor Bioscience
Factor Bioscience
2011, Cambridge (United States), Seed
Developer of genomic technologies to treat disease and improve health
$1M
55/100
8th
Logo for Epredia
Epredia
2019, United Kingdom, Unfunded
Developer of in-vitro diagnostic test for cancer
-
-
55/100
9th
Logo for Enara Bio
Enara Bio
2016, Oxford (United Kingdom), Series B
Developer of T-cell based cancer-cell interface for therapeutics
$84.1M
53/100
10th
Logo for Octant
Octant
2017, Los Angeles (United States), Series B
Provider of human cell interaction platform for drug discovery
$115M
51/100
18th
Logo for Genechem
Genechem
2002, Shanghai (China), Series C
Products and services in molecular biology
$56.4M
46/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Genechem's competitors? Click here to see the top ones

Genechem's Investments and acquisitions

Genechem has not made any acquisitions yet. Genechem has made 12 investments.
Here is the list of latest three $investments:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Nov 15, 2013
Investments
2011
Cincinnati (United States)
Jun 04, 2013
Investments
2007
Cincinnati (United States)
Nov 02, 2012
Investments
2002
Montreal (Canada)
lockWant to know more about where corporates are investing? Sign up today!
See all investments by Genechem

Reports related to Genechem

Here is the latest report on Genechem's sector:

News related to Genechem

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Genechem

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford